Canada markets close in 4 hours 1 minute

Teva Pharmaceutical Industries Limited (TEVJF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
17.240.00 (0.00%)
As of 09:50AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 19.40B
Enterprise Value 36.35B
Trailing P/E 900.00
Forward P/E 9.50
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.26
Price/Book (mrq)2.80
Enterprise Value/Revenue 2.27
Enterprise Value/EBITDA 27.52

Trading Information

Stock Price History

Beta (5Y Monthly) 0.91
52-Week Change 3111.52%
S&P500 52-Week Change 323.76%
52 Week High 318.00
52 Week Low 37.03
50-Day Moving Average 313.59
200-Day Moving Average 311.20

Share Statistics

Avg Vol (3 month) 379
Avg Vol (10 day) 3210
Shares Outstanding 51.13B
Implied Shares Outstanding 61.14B
Float 81.13B
% Held by Insiders 10.56%
% Held by Institutions 18.97%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 41.05
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Nov 28, 2017
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -2.99%
Operating Margin (ttm)17.28%

Management Effectiveness

Return on Assets (ttm)4.84%
Return on Equity (ttm)-9.67%

Income Statement

Revenue (ttm)16B
Revenue Per Share (ttm)14.28
Quarterly Revenue Growth (yoy)4.30%
Gross Profit (ttm)N/A
EBITDA 4.46B
Net Income Avi to Common (ttm)-478M
Diluted EPS (ttm)-0.42
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.99B
Total Cash Per Share (mrq)2.64
Total Debt (mrq)19.94B
Total Debt/Equity (mrq)264.33%
Current Ratio (mrq)0.89
Book Value Per Share (mrq)6.43

Cash Flow Statement

Operating Cash Flow (ttm)1.39B
Levered Free Cash Flow (ttm)3.57B